HNP Capital’s Amgen AMGN Stock Holding History

HNP Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-43,177	Closed	-$9.96M	–	129
2020 Q1	$9.96M	Buy	+43,177	New	+$9.43M	1.48%	14
2019 Q4	–	Sell	-1,068	Closed	-$206K	–	113
2019 Q3	$206K	Sell	1,068 -233	-18%	-$44.7K	0.11%	109
2019 Q2	$240K	Sell	1,301 -67	-5%	-$12K	0.14%	94
2019 Q1	$260K	Sell	1,368 -130	-9%	-$24.8K	0.16%	91
2018 Q4	$292K	Buy	+1,498	New	+$292K	0.2%	89

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HNP Capital's AMGN Position: Q2 2020 in Review

HNP Capital sold out of Amgen (AMGN) in Q2 2020, closing a stake of 43,177 shares — an estimated $9.96M sold.

HNP Capital first reported a position in AMGN in Q4 2018 and held it in 5 quarters. The position peaked at $9.96M in Q1 2020. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

HNP Capital reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
HNP Capital sold 43,177 Amgen shares in Q2 2020, an estimated $9.96M.
HNP Capital first reported a position in Amgen in Q4 2018 and held it in 5 quarters.
HNP Capital's Amgen position peaked at $9.96M in Q1 2020.
2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on HNP Capital's 13F filing for Q2 2020, filed 6 Jul 2020.